Literature DB >> 25988726

Multifunctional envelope-type mesoporous silica nanoparticles for pH-responsive drug delivery and magnetic resonance imaging.

Yan Chen1, Kelong Ai2, Jianhua Liu3, Guoying Sun4, Qi Yin4, Lehui Lu5.   

Abstract

A novel multifunctional envelope-type mesoporous silica nanoparticle (MEMSN) system combining the merits of pH-responsiveness, non-toxicity and biological specificity, is demonstrated for drug delivery and magnetic resonance imaging (MRI). This system is constructed by immobilizing acetals on the surface of mesoporous silica, and then coupling to ultra small lanthanide doped upconverting nanoparticle, which act as a gate keeper. The anticancer drug DOX is thus locked in the pores, and its burst release can be achieved under acidic environment on account of the hydrolyzation reactions of acetals. The nanogated drug release system is highly efficacious for cancer therapy both in vitro and in vivo. Importantly, the nanocomposite could be harmlessly metabolized and degraded into apparently non-toxic products within a few days. The nanoscale effect of the system allows for passive tumor targeting and increased tumor accumulation of the probes via the enhanced permeation and retention (EPR) effect, which is visualized by MRI in vivo. Therefore, such nanosystem should be of great significance in the future development of highly efficient and tumor targeted drug delivery vehicles for cancer chemotherapy.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Drug delivery; EPR effect; Magnetic resonance imaging; pH-responsiveness

Mesh:

Substances:

Year:  2015        PMID: 25988726     DOI: 10.1016/j.biomaterials.2015.05.003

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  27 in total

Review 1.  Theragnostic potentials of core/shell mesoporous silica nanostructures.

Authors:  Aswathy Ravindran Girija; Sivakumar Balasubramanian
Journal:  Nanotheranostics       Date:  2019-01-01

2.  A Hyaluronidase-Responsive Nanoparticle-Based Drug Delivery System for Targeting Colon Cancer Cells.

Authors:  Mingzhen Zhang; Changlong Xu; Liuqing Wen; Moon Kwon Han; Bo Xiao; Jun Zhou; Yuchen Zhang; Zhan Zhang; Emilie Viennois; Didier Merlin
Journal:  Cancer Res       Date:  2016-10-14       Impact factor: 12.701

3.  Advanced Functional Nanomaterials for Theranostics.

Authors:  Haoyuan Huang; Jonathan F Lovell
Journal:  Adv Funct Mater       Date:  2016-11-07       Impact factor: 18.808

4.  Tumor-specific macrophage targeting through recognition of retinoid X receptor beta.

Authors:  Tang Tang; Yushuang Wei; Jinyoung Kang; Zhi-Gang She; Dokyoung Kim; Michael J Sailor; Erkki Ruoslahti; Hong-Bo Pang
Journal:  J Control Release       Date:  2019-03-11       Impact factor: 9.776

5.  In vivo Targeting of Liver Cancer with Tissue- and Nuclei-Specific Mesoporous Silica Nanoparticle-Based Nanocarriers in mice.

Authors:  Ziqiang Ding; Dujin Wang; Wei Shi; Xiaomei Yang; Siliang Duan; Fengzhen Mo; Xiaoqiong Hou; Aiqun Liu; Xiaoling Lu
Journal:  Int J Nanomedicine       Date:  2020-10-29

6.  Intrabilayer 64Cu Labeling of Photoactivatable, Doxorubicin-Loaded Stealth Liposomes.

Authors:  Dandan Luo; Shreya Goel; Hai-Jun Liu; Kevin A Carter; Dawei Jiang; Jumin Geng; Christopher J Kutyreff; Jonathan W Engle; Wei-Chiao Huang; Shuai Shao; Chao Fang; Weibo Cai; Jonathan F Lovell
Journal:  ACS Nano       Date:  2017-12-05       Impact factor: 15.881

Review 7.  Monitoring/Imaging and Regenerative Agents for Enhancing Tissue Engineering Characterization and Therapies.

Authors:  Daniela Y Santiesteban; Kelsey Kubelick; Kabir S Dhada; Diego Dumani; Laura Suggs; Stanislav Emelianov
Journal:  Ann Biomed Eng       Date:  2015-12-21       Impact factor: 4.219

Review 8.  Mesoporous silica nanoparticles for stimuli-responsive controlled drug delivery: advances, challenges, and outlook.

Authors:  Yuanhui Song; Yihong Li; Qien Xu; Zhe Liu
Journal:  Int J Nanomedicine       Date:  2016-12-20

Review 9.  Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical Imaging.

Authors:  Nirilanto Ramamonjisoa; Ellen Ackerstaff
Journal:  Front Oncol       Date:  2017-01-31       Impact factor: 6.244

10.  A novel pH-sensitive carrier for the delivery of antitumor drugs: histidine-modified auricularia auricular polysaccharide nano-micelles.

Authors:  Yingying Wang; Pingfei Li; Fen Chen; Lianqun Jia; Qihao Xu; Xiumei Gai; Yibin Yu; Yan Di; Zhihong Zhu; Yanyao Liang; Mengqi Liu; Weisan Pan; Xinggang Yang
Journal:  Sci Rep       Date:  2017-07-06       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.